Intense Regulated Pulsed Light Technology (IRPL) is a modern and state-of-the-art method of managing dry eyes, and provides a long-lasting solution to improve visual comfort by restoring the function of meibomian glands, improving secretion and stabilising the lipid layer of the tear film.
There are 60-80 Meibomian Glands located in the upper and lower eyelids. These glands produce the oils that form a lipid layer on the outermost part of the tear film, protecting the eyes from tear evaporation.
The tears serve to overcome the micro-irregularities of the eye’s surface and offer an optically smooth surface.
Dry Eye Disease, which can arise from multiple factors, starts off with tear film instability that is accompanied by increased tear osmolarity which activates stress signaling pathways in the ocular surface and immune cells.
This in turn triggers production of innate inflammatory molecules that initiate a vicious self-repeating cycle that may lead to further deterioration in tear function and worsening of symptoms. Numerous environmental and internal factors can contribute to this inflammatory cycle making Dry Eye a multi-factorial disease.
Dry, burning, red, permanently fatigued, and paradoxically watery eyes are symptoms of Dry Eye Disease. Patients might also face problems with wearing contact lenses and have pronounced sensitivity to light.
Apart from experiencing eye pain, patients may have more serious complications, such as infections, styes, or corneal ulcers.
Currently temporary solutions include eye drops, which reduce the discomfort felt by patients, however, the underlying problem with dry eyes remains untreated.
Meibomian dysfunction is the primary cause of dry eye. Tearstim IRPL provides a long-lasting solution to improve visual comfort by restoring the function of Meibomian Glands.
What truly sets Tearstim apart is the neuro-stimulatory component made possible through IRPL technology. The flashes emitted stimulate the parasympathetic nerve which supplies the Meibomian Glands.
A neurological stimulation of the parasympathetic nerve:
Additionally, the following effects have been proposed to explain the clinical benefits observed with IRPL:
The treatment only takes a few minutes per session:
Since 2013, more than 16 clinical studies with over 550 patients have been conducted using Intense Regulated Pulsed Light Technology (IRPL) in Europe, Asia and Australasia.
A considerable improvement in the symptoms perceived by patients and a 90% satisfaction rate after the first 2 treatments, improvements may be felt following the initial session and increases over time with following treatments.